Business context and reporting period
Markel Corporation’s Form 10-K covers the fiscal year ended December 31, 2022; it is an annual report, not a standalone fourth-quarter filing. Markel operates three principal financial engines: specialty insurance and reinsurance, investments, and Markel Ventures, a portfolio of operating businesses. The filing identifies the registrant as Markel Corporation.
Financial results and position
| Metric | 2022 | 2021 |
|---|---|---|
| Total operating revenues | $11.68 billion | $12.85 billion |
| Net income (loss) to shareholders | $(214) million | $2.43 billion |
| Net income (loss) to common shareholders | $(250) million; $(23.57) per diluted share | $2.39 billion; $176.51 per diluted share |
| Comprehensive income (loss) to shareholders | $(1.31) billion | $2.08 billion |
| Earned premiums | $7.59 billion, up 17% | $6.50 billion |
| Underwriting profit / combined ratio | $627 million / 91.7% | $628 million / 90.3% |
| Net investment income | $447 million | $367 million |
| Net investment gains (losses) | $(1.60) billion | $1.98 billion |
| Operating cash flow | $2.71 billion | $2.27 billion |
| Invested assets at year-end | $27.42 billion | $28.29 billion |
| Shareholders’ equity / book value per common share | $13.07 billion / $929.27 | $14.72 billion / $1,036.20 |
| Debt to capital ratio | 24% | 23% |
Markel Ventures reported $4.76 billion in revenue, $325 million in operating income, $506 million in EBITDA and $193 million in net income to shareholders. Revenue grew 31%, while operating income grew 19%.
At year-end, total assets were $49.79 billion and total liabilities were $36.14 billion. Senior long-term and other debt totaled $4.10 billion; cash and cash equivalents plus restricted cash were $5.22 billion. The company reported $3.7 billion of holding-company invested assets, no borrowings under its $300 million corporate revolver, and stated it believed liquidity was adequate. Insurance subsidiaries’ statutory capital and surplus significantly exceeded regulatory requirements.
Material changes versus 2021
- Operating revenue fell 9%, and shareholders reported a net loss, primarily reflecting the reversal from $1.98 billion of investment gains in 2021 to $1.60 billion of losses in 2022. Equity market declines drove most investment losses; rising interest rates reduced fixed-maturity values.
- Other comprehensive loss included $1.41 billion of pre-tax unrealized losses on available-for-sale investments. Book value per common share fell 10% to $929.27.
- Underwriting premiums increased, but underwriting profit was essentially flat. The consolidated combined ratio worsened 1.4 points to 91.7%, mainly due to less favorable prior-year reserve development in Insurance, partly offset by a lower expense ratio.
- Insurance segment underwriting profit decreased 21% to $550 million; its combined ratio rose to 91.6% from 87.3%. Reinsurance returned to underwriting profit of $84 million from a $55 million loss; its combined ratio improved to 92.1% from 105.3%.
- Markel Ventures’ growth reflected acquisitions completed in 2021, higher demand and prices. Increased labor and materials costs constrained margins.
- Markel sold its controlling interests in Velocity and Volante, recognizing gains of $107 million and $119 million, respectively. The Nephila ILS business recorded an $80 million goodwill impairment; Nephila assets under management were $7.2 billion at year-end.
Outlook, risks, contingencies and unusual items
The filing provides no specific consolidated earnings or revenue guidance. Management described rate increases as moderating in 2022, with single-digit rate decreases in some lines, while maintaining underwriting discipline. It cited inflation, social inflation, rising interest rates, market volatility and supply-chain pressures as important uncertainties. Management said further favorable prior-year reserve development in 2023 was possible but cautioned against relying on that trend; its reasonably likely range was adverse development of 2% (about $200 million) to favorable development of 6% (about $800 million) of year-end 2022 net loss reserves.
- Net prior-year reserve development was favorable by $167 million in 2022, versus $480 million in 2021. Insurance experienced adverse development in professional and general liability, amid higher claim frequency and severity, economic and social inflation, and delayed court proceedings.
- Reported net losses included $46 million from Hurricane Ian and $36 million from the Russia-Ukraine conflict. COVID-19 reserve estimates remain subject in some cases to judicial review. Estimates for these events may change as claims and reinsurance information develops.
- Reinsurance recoverables were $8.45 billion, including $1.4 billion due from Nephila-managed reinsurers. Markel disclosed collateral of $5.0 billion securing $8.4 billion in recoverables, as well as potential exposure under certain reinsurance and fronting arrangements.
- The March 2022 Markel CATCo buy-out generated $102 million of expense, net of insurance proceeds, and included a $142.7 million uncollateralized tail-risk cover. Markel also disclosed a separate $20.1 million remaining investment in CATCo Re.
- One Markel Ventures subsidiary was out of compliance with covenants on a credit facility with $97.9 million outstanding; it was negotiating an amendment. Management did not expect a material consolidated effect.
- A shareholder representative’s CVR litigation seeks damages, interest and other relief. Markel says the claims are without merit and that a material loss is remote.
- Risks include catastrophe severity and climate-related events, reserve uncertainty, broker concentration, reinsurance counterparty credit, concentrated equity investments, regulation, cybersecurity, and the ability to retain third-party ILS capital. The top three brokers represented 28% of underwriting-segment gross premiums written.
KPMG issued unqualified opinions on the financial statements and internal control over financial reporting. Loss-reserve estimation for underwriting operations was identified as a critical audit matter. Management reported effective disclosure controls and internal control over financial reporting.
Important facts for investors to verify
- How investment portfolio movements, particularly the $1.60 billion net investment loss and fixed-maturity unrealized losses, affect future earnings, capital and book value.
- Whether reserve development in professional and general liability confirms or challenges management’s estimates and stated 2023 reserve-development range.
- Collection quality and collateral adequacy for the $8.45 billion of reinsurance recoverables, including exposures to Nephila and program-services counterparties.
- Whether Markel Ventures can sustain revenue growth while recovering higher labor, materials and shipping costs, and whether the subsidiary covenant breach is resolved.
- Whether ILS assets under management and fee income stabilize after catastrophe losses, investor redemptions and the sale of Velocity and Volante.
- The timing and outcome of the CVR litigation and any remaining CATCo tail-risk exposure.